Physiologic testosterone levels in normal men suppress high-density lipoprotein cholesterol levels.
about
Androgen replacement therapy in the aging maleTestosterone hormone replacement therapy: state-of-the-art and emerging technologiesEffects on lipoprotein particles of long-term dehydroepiandrosterone in elderly men and women and testosterone in elderly men.Testosterone supplementation therapy for older men: potential benefits and risks.New modalities of transdermal testosterone replacement.Testosterone-induced effects on lipids and inflammationBenign prostatic hyperplasia: dietary and metabolic risk factors.Insulin: a novel agent in the pathogenesis of prostate cancer.Nasal steroid perspective: knowledge and attitudes.Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy.Androgen therapy improves muscle mass and strength but not muscle quality: results from two studies.Testosterone administration to men increases hepatic lipase activity and decreases HDL and LDL size in 3 wk.Acute effects of testosterone on intracellular Ca2+ kinetics in rat coronary endothelial cells are exerted via aromatization to estrogens.Sex steroids and heart rate variability in patients after myocardial infarction.AR CAG repeat length is not associated with serum gonadal steroids and lipid levels in healthy men.Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.Androgen therapy in the aging male: assessing the effect on heart diseaseAndrogens and cardiovascular disease in men and women
P2860
Q24551170-F6B58A8C-F4BC-4BB7-BA7C-BB41C19EB13AQ28244508-B25F0215-23D0-4651-97CD-16A634C48EF3Q33786842-2E5E1847-9688-423F-A53E-31E410911879Q34171397-4406E556-ED90-4C6C-BDAD-6672B9C1BA61Q36116365-78199FED-04A3-493F-A564-D9640FF7AB22Q36771684-C05624BA-F844-4EFE-952D-252D2381C302Q37075987-A3DCC5E1-157A-4AE8-9F4D-EA583ED57B85Q37229843-5295A3D7-EDE5-4B2A-9EB2-8D1C43932589Q43236137-29A12A5E-F9A1-4440-83B2-06A6FB4F89E8Q43758645-EE50B41E-B7A4-45BB-87DF-3DDF7DCA3EA2Q44361952-BF9C89B9-FDD7-4912-9D5D-B34DF8E5DE74Q44433201-39ACBDEC-446B-4637-9417-0CD1D8B92337Q44730458-93D9842D-3994-439F-A959-35684E6E430BQ44844505-F870B22C-A286-4246-8F3C-DE4B366D0729Q46461154-94CA5C13-3AE1-4DB6-9798-427FE83E34C7Q53594509-DF4650CF-2F7F-48D2-BAF6-4F73FEF3BC1AQ58134737-8ED56313-1845-400B-ADD1-490901190F56Q58248183-71949CC5-8288-4F4F-8371-9F339A3E618A
P2860
Physiologic testosterone levels in normal men suppress high-density lipoprotein cholesterol levels.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Physiologic testosterone level ...... ipoprotein cholesterol levels.
@ast
Physiologic testosterone level ...... ipoprotein cholesterol levels.
@en
type
label
Physiologic testosterone level ...... ipoprotein cholesterol levels.
@ast
Physiologic testosterone level ...... ipoprotein cholesterol levels.
@en
prefLabel
Physiologic testosterone level ...... ipoprotein cholesterol levels.
@ast
Physiologic testosterone level ...... ipoprotein cholesterol levels.
@en
P2093
P1476
Physiologic testosterone level ...... ipoprotein cholesterol levels.
@en
P2093
P304
P356
10.7326/0003-4819-116-12-967
P407
P433
P577
1992-06-01T00:00:00Z